DECR2 anticorps (N-Term)
Aperçu rapide pour DECR2 anticorps (N-Term) (ABIN629763)
Antigène
Voir toutes DECR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- DECR2 antibody was raised against the N terminal of DECR2
-
Purification
- Purified
-
Immunogène
- DECR2 antibody was raised using the N terminal of DECR2 corresponding to a region with amino acids MAQPPPDVEGDDCLPAYRHLFCPDLLRDKVAFITGGGSGIGFRIAEIFMR
-
-
-
-
Indications d'application
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
DECR2 Blocking Peptide, (ABIN5613173), is also available for use as a blocking control in assays to test for specificity of this DECR2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DECR2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DECR2 (2,4-Dienoyl CoA Reductase 2, Peroxisomal (DECR2))
-
Autre désignation
- DECR2
-
Sujet
- DECR2 is auxiliary enzyme of beta-oxidation. It participates in the degradation of unsaturated fatty enoyl-CoA esters having double bonds in both even- and odd-numbered positions in peroxisome. It catalyzes the NADP-dependent reduction of 2,4-dienoyl-CoA to yield trans-3-enoyl-CoA and has activity towards short and medium chain 2,4-dienoyl-CoAs, but also towards 2,4,7,10,13,16,19-docosaheptaenoyl-CoA, suggesting that it does not constitute a rate limiting step in the peroxisomal degradation of docosahexaenoic acid.
-
Poids moléculaire
- 32 kDa (MW of target protein)
Antigène
-